Martina Sedinic Lacko - Hematology Department, University Hospital Dubrava

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

P-258 Carfilzomib in Relapsed/refractory Multiple Myeloma Patients – Real World Evidence: Experiences of the Croatian Cooperative Group for Hematologic Diseases (KROHEM)

Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia (2023): S178-S178

引用0浏览0引用

Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients

Marko Lucijanic,Ida Tjesic-Drinkovic,Nevenka Piskac Zivkovic,Frane Pastrovic,Zrinka Rob,Mersiha Bacevac,Martina Sedinic Lacko,Eleonora Dzambas,Barbara Medic,Ivan Vukoja,Iva Busic,Ivica Grgurevic,Ivica Luksic,Bruno Barsic

Life（2023）

引用0浏览0WOS引用

Hypoosmolar and Hyperosmolar COVID-19 Patients Are Predisposed to Dismal Clinical Outcomes

Marko Lucijanic,Ivan Krecak,David Cicic,Marko Milosevic,Damir Vukoja,Ivona Kovacevic,Ivan Marasovic,Martina Sedinic Lacko,Josip Bakovic,Zeljko Jonjic,Tamara Vasilj,Josip Stojic,Armin Atic

Scandinavian journal of clinical and laboratory investigationno. 6 (2023): 397-402

引用0浏览0WOS引用

P1621: INCIDENCE, RISK FACTORS AND MORTALITY ASSOCIATED WITH MAJOR BLEEDING EVENTS IN HOSPITALIZED COVID-19 PATIENTS, TERTIARY CENTER EXPERIENCE

Marko Lucijanic,Ida Tjesic-Drinkovic,Nevenka Piskac Zivkovic,Frane Pastrovic,Zrinka Rob,Mersiha Bacevac,Martina Sedinić Lacko,Eleonora Dzambas,Barbara Medic,Ivan Vukoja,Iva Busic,Ivica Grgurevic,Ivica Luksic,Bruno Barsic

HemaSphere（2023）

引用0浏览0引用

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients

Marko Lucijanic,Ivana Jurin,Martina Sedinic Lacko,Ena Soric,Anica Sabljic,Ivan Krecak,Josko Mitrovic,Daniela Marelic, Zvonimir Kremer,Irzal Hadzibegovic,Tomo Lucijanic,Rajko Kusec

Thrombosis Research (2022): 37-39

引用0浏览0WOS引用

Gradual increase in red cell distribution width is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients

Marko Lucijanic,Ena Soric,Martina Sedinic Lacko,Anica Sabljic,Ivan Krecak,Petra Bistrovic,Ana Jordan,Sime Manola,Ozren Jaksic,Tomo Lucijanic,Lovorka Derek,Rajko Kusec

JOURNAL OF MEDICAL VIROLOGY（2022）

引用1浏览0WOS引用

Comparison of IMPROVE, Modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC Risk Scores for Venous and Arterial Thrombotic Events Prediction in Hospitalized COVID-19 Patients

Marko Lucijanić,Ivana Jurin,Martina Sedinić Lacko,Ena Sorić,Anica Sabljić,Ivan Krečak,Joško Mitrović,Daniela Marelic, Zvonimir Kremer,Irzal Hadžibegović,Tomo Lucijanić,Rajko Kušec

Thrombosis research (2022): 37-39

引用0浏览0引用

No Evident Prognostic Benefit of Statin Use in Diffuse Large B-Cell Lymphoma Patients with Unfavorable Disease Features Treated with R-DA-EPOCH

Anica Sabljic,Martina Sedinic Lacko,Rajko Kusec,Vlatko Pejsa,Marko Lucijanic

PHARMACOLOGYno. 11-12 (2022): 623-627

引用0浏览0WOS引用

Gradual Increase in Red Cell Distribution Width is Similarly Prognostic for In‐hospital Mortality in Both Anemic and Non‐anemic COVID‐19 Patients

Marko Lucijanić,Ena Sorić,Martina Sedinić Lacko,Anica Sabljić,Ivan Krečak,Petra Bistrović,Ana Jordán,Šime Manola,Ozren Jakšić,Tomo Lucijanić,Lovorka Đerek,Rajko Kušec

Journal of medical virologyno. 8 (2022): 3509-3511

引用1浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn